EPO and Stroke: EPO decreases inflammatory mediators (15, 16), and thus has been suggested for various clinical indications such as stroke, multiple sclerosis (MS), schizophrenia, retinopathy, Parkinson’s disease, epilepsy, brain trauma and spinal cord injury (17).